430 related articles for article (PubMed ID: 15649369)
1. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
Yap MW; Nisole S; Stoye JP
Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
[TBL] [Abstract][Full Text] [Related]
3. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
4. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
5. General Model for Retroviral Capsid Pattern Recognition by TRIM5 Proteins.
Wagner JM; Christensen DE; Bhattacharya A; Dawidziak DM; Roganowicz MD; Wan Y; Pumroy RA; Demeler B; Ivanov DN; Ganser-Pornillos BK; Sundquist WI; Pornillos O
J Virol; 2018 Feb; 92(4):. PubMed ID: 29187540
[TBL] [Abstract][Full Text] [Related]
6. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L; Sebastian S; Sayah DM; Luban J
J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
[TBL] [Abstract][Full Text] [Related]
7. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
[TBL] [Abstract][Full Text] [Related]
8. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
9. Rhesus TRIM5α disrupts the HIV-1 capsid at the inter-hexamer interfaces.
Zhao G; Ke D; Vu T; Ahn J; Shah VB; Yang R; Aiken C; Charlton LM; Gronenborn AM; Zhang P
PLoS Pathog; 2011 Mar; 7(3):e1002009. PubMed ID: 21455494
[TBL] [Abstract][Full Text] [Related]
10. Role of Human TRIM5α in Intrinsic Immunity.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():97. PubMed ID: 22435067
[TBL] [Abstract][Full Text] [Related]
11. The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.
Keckesova Z; Ylinen LM; Towers GJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10780-5. PubMed ID: 15249687
[TBL] [Abstract][Full Text] [Related]
12. A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection.
Nakayama EE; Miyoshi H; Nagai Y; Shioda T
J Virol; 2005 Jul; 79(14):8870-7. PubMed ID: 15994780
[TBL] [Abstract][Full Text] [Related]
13. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
14. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
Passerini LD; Keckesova Z; Towers GJ
J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
[TBL] [Abstract][Full Text] [Related]
15. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
[TBL] [Abstract][Full Text] [Related]
16. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
17. Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
Li X; Song B; Xiang SH; Sodroski J
Virology; 2007 Sep; 366(2):234-44. PubMed ID: 17543365
[TBL] [Abstract][Full Text] [Related]
18. The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.
Song B; Gold B; O'Huigin C; Javanbakht H; Li X; Stremlau M; Winkler C; Dean M; Sodroski J
J Virol; 2005 May; 79(10):6111-21. PubMed ID: 15857996
[TBL] [Abstract][Full Text] [Related]
19. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
20. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
